Percutaneous transluminal angioplasty with stenting in the treatment of lower limb occlusive arteriosclerosis

IntroductionWith the advancement of minimally invasive techniques, percutaneous transluminal angioplasty with stenting (PTAS) has emerged as a significant approach for managing lower limb arteriosclerosis obliterans (ASO). AimTo analyze the clinical efficacy of PTAS in patients with lower limb occlusive ASO. Materials and methodsA total of 96 ASO patients admitted to our hospital were collected for this study.The control group (n=48) underwent percutaneous transluminal angioplasty (PTA) while the observation group (n=48) received PTAS treatment.The effectiveness of the treatment was evaluated 30 days post-operation.Pre-operative and post-operative measurements included the Ankle-Brachial Index (ABI), claudication distance, and SF-36 quality of life scores.Post-operative complications and the rate of target lesion revascularization (TLR) were also recorded.The observation group had 29 markedimprovements and 17 effective cases, bringing the total effectiveness rate to 95.83%, which was significantly higher than the control group (p=0.045).Both groups showed significant improvement in ABI, claudication distance, and SF-36 scores after treatment (p<0.05 for all), with the observation group showing significantly better results than the control group (p<0.05 for all).There was no significant difference in the total incidence of complications between the two groups (p=0.2389),however, the TLR occurrence rate was significantly lower in the observation group (p=0.0411). ConclusionsThis study highlights the significant advantages of PTAS in treating ASO, including improving overall effectiveness, enhancing functional indicators, and reducing the rate of TLR, thus providing strong evidence for clinicians when selecting treatment methods for patients with lower limb occlusive arteriosclerosis.